CC BY-NC-ND 4.0 · Endosc Int Open 2023; 11(06): E613-E617
DOI: 10.1055/a-2095-0098
Innovation forum

Initial experience of transpapillary gallbladder biopsy using newly designed device delivery system

1   Department of Gastroenterology, Tonan Hospital, Sapporo, Japan (Ringgold ID: RIN36737)
,
Yusuke Tomita
1   Department of Gastroenterology, Tonan Hospital, Sapporo, Japan (Ringgold ID: RIN36737)
,
Masahiro Yoshida
1   Department of Gastroenterology, Tonan Hospital, Sapporo, Japan (Ringgold ID: RIN36737)
,
Kou Sasaki
1   Department of Gastroenterology, Tonan Hospital, Sapporo, Japan (Ringgold ID: RIN36737)
,
Takayuki Imagawa
1   Department of Gastroenterology, Tonan Hospital, Sapporo, Japan (Ringgold ID: RIN36737)
,
Kotaro Morita
1   Department of Gastroenterology, Tonan Hospital, Sapporo, Japan (Ringgold ID: RIN36737)
,
Hideyuki Ihara
1   Department of Gastroenterology, Tonan Hospital, Sapporo, Japan (Ringgold ID: RIN36737)
,
Takeyoshi Minagawa
1   Department of Gastroenterology, Tonan Hospital, Sapporo, Japan (Ringgold ID: RIN36737)
,
Yutaka Okagawa
1   Department of Gastroenterology, Tonan Hospital, Sapporo, Japan (Ringgold ID: RIN36737)
,
Michiaki Hirayama
1   Department of Gastroenterology, Tonan Hospital, Sapporo, Japan (Ringgold ID: RIN36737)
,
Tetsuya Sumiyoshi
1   Department of Gastroenterology, Tonan Hospital, Sapporo, Japan (Ringgold ID: RIN36737)
,
Hitoshi Kondo
1   Department of Gastroenterology, Tonan Hospital, Sapporo, Japan (Ringgold ID: RIN36737)
› Author Affiliations

Abstract

Transpapillary gallbladder biopsy has been reported for the diagnosis of gallbladder disease, and this procedure requires special biopsy forceps or a large-diameter pusher catheter. We retrospectively examined consecutive patients who underwent transpapillary gallbladder biopsy using a newly designed device delivery system (Endosheather; Piolax Medical Device, Kanagawa, Japan). We evaluated 11 patients (median age, 71 years [28–85]) who underwent transpapillary gallbladder biopsy from June 2021 to July 2022. The selective gallbladder cannulation and delivery system insertion success rate was 90.9% (10/11). The target lesion biopsy success rate was 63.6% (7/11). The biopsy time (i.e., time to completion of biopsy after successful guidewire placement) was 8.7 (5.4–32.7) min. In 1 patient in whom all 6 gallbladder bile juice cytology results were benign, the biopsy result was suspicious of adenocarcinoma. The final diagnosis for this patient was gallbladder cancer. Adverse events occurred in 2 patients. In 1 patient, acute cholecystitis occurred and required emergency surgery. Transpapillary gallbladder biopsy using the Endosheather is a potential option for the diagnosis of gallbladder disease. A good indication for this technique is considered to be wall thickening at the gallbladder fundus, where it is difficult to differentiate between benign and malignant lesions by imaging modalities such as ultrasonography or endoscopic ultrasound. The addition of transpapillary gallbladder biopsy may be advantageous when performing bile juice cytology using a nasogallbladder drainage tube for the diagnosis of gallbladder disease.



Publication History

Received: 23 December 2022

Accepted after revision: 08 May 2023

Accepted Manuscript online:
16 May 2023

Article published online:
29 June 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany